Influenza antiviral resistance in the Asia-Pacific region during 2011.
about
Clinical Implications of Antiviral Resistance in InfluenzaViral-bacterial interactions-therapeutic implicationsEpidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors.E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant RecipientComputation-guided discovery of influenza endonuclease inhibitors.Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.A review of neuraminidase inhibitor susceptibility in influenza strains.Identification of single amino acid substitutions (SAAS) in neuraminidase from influenza a virus (H1N1) via mass spectrometry analysis coupled with de novo peptide sequencing.Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.Peramivir and laninamivir susceptibility of circulating influenza A and B viruses.Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.Development of a magnetic electrochemical bar code array for point mutation detection in the H5N1 neuraminidase gene.Soloxolone methyl inhibits influenza virus replication and reduces virus-induced lung inflammation.Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
P2860
Q26782746-A2A79688-52B6-4833-8962-57D74A18DBBBQ26825261-7E81A499-BB1C-4AB2-8AC5-1D294ED39444Q28544035-234E080E-F1B1-40DE-B87C-E14D1575DBA0Q35960631-9E8BA042-9903-4CB5-9A15-9F2D0C357701Q36250190-A145FEFD-FE23-4F83-9589-09D5B73E807DQ37523332-BD168EE3-1CBB-4ADD-97CC-925A82B6712BQ38149216-3BD9DBB9-1B3E-4107-86F1-E6A996AACBBEQ38209673-8229F379-FEFA-4A84-889F-60A69906E2BFQ38258646-5122458E-F7B3-4D2F-A7E6-25B6A8CB2E82Q39475822-18545A3E-5A90-4FA8-AE0D-45E04597E104Q41095623-C4F315D7-D47C-4ADB-9F5E-9A93B7264142Q41854401-5BA69847-7E98-44E7-B125-7123D5ACBDD6Q41933615-D254DB21-04A0-4464-AFE9-34F190F33B3FQ42283472-573B2C24-AFE1-4DEC-9B45-D0A51D39D6BCQ42629986-1394C3A2-A0E5-4A0E-8687-BC63DEA7E080Q47555226-EF5E1901-0FE3-40CD-B989-06B8A33C7987
P2860
Influenza antiviral resistance in the Asia-Pacific region during 2011.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@ast
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@en
type
label
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@ast
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@en
prefLabel
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@ast
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@en
P2093
P50
P1433
P1476
Influenza antiviral resistance in the Asia-Pacific region during 2011.
@en
P2093
Alison Kesson
Avram Levy
Craig Redden
Dominic E Dwyer
Fahimeh Rahnamal
Frances Hammill
Geethani Wickramasinghe
Gina Papadakis
Jan Williamson
P304
P356
10.1016/J.ANTIVIRAL.2012.12.016
P50
P577
2012-12-25T00:00:00Z